CAGRI-SEMA
For Research Use Only | Not for Human or Veterinary Use
Description:
Cagri-Sema is a co-formulation combining cagrilintide, a long-acting acylated amylin receptor agonist analogue, with GLP-1-SG, a long-acting GLP-1 receptor agonist analogue. This dual-mechanism co-formulation targets complementary metabolic pathways and is studied within metabolic regulation research.
Scientific Specifications:
- Compound Name: Cagri-Sema (Cagrilintide + GLP-1-SG)
- Type: Dual Peptide Co-formulation (Amylin Analogue + GLP-1 Analogue)
- Molecular Formulas: C₁₉₄H₃₁₂N₅₄O₅₉S₂ (Cagrilintide) + C₁₈₇H₂₉₁N₄₅O₅₉ (GLP-1-SG)
- Molecular Weights: ~4409.01 g/mol (Cagrilintide) + ~4113.58 g/mol (GLP-1-SG)
- CAS Numbers: 1415456-99-3 (Cagrilintide) / 910463-68-2 (GLP-1-SG)
- PubChem CIDs: 137517361 (Cagrilintide) / 56843341 (GLP-1-SG)
- Form: Lyophilized powder
- Storage: Store dry in a cool, dark environment (2°C to 8°C)
Research Context:
Cagri-Sema is referenced in research involving:
- Dual amylin and GLP-1 receptor activation
- Glucose metabolism research
- Obesity research models
- Gastric-emptying research
- Pancreatic signaling pathways
- Comparative research versus single-agent GLP-1 receptor agonist approaches
Intended Use:
This product is intended strictly for laboratory research applications only by qualified scientific personnel. It is not approved for human or animal consumption, and may not be used in foods, drugs, supplements, cosmetics, or diagnostics.
Legal Disclaimer:
The statements provided and this compound have not been evaluated by the U.S. Food and Drug Administration. No claims are made regarding diagnosis, treatment, or prevention of any disease. Use is restricted to qualified researchers operating in certified laboratory environments.
Terms of Sale:
By purchasing this product, the buyer affirms they are a qualified researcher or institutional purchaser, fully responsible for proper handling, storage, and legal compliance.
